Glenzocimab

Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.

Product Specifications

CAS Number

2101829-58-5

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

10-4194-100 100 µg

Monoclonal Antibody to Rat NKp46 (Clone: WEN23)

Ask

View Details

P8680 200 mL/Kit

Human Peripheral Blood Monocyte Isolation Solution Kit

Ask

View Details

NBP1-43392IR 0.1 mL

Mouse Monoclonal P-Selectin/CD62P Antibody (AK-4) [DyLight 755]

Ask

View Details

E47R14269 100 µL

DENND1A Rabbit pAb

Ask

View Details

PPT-16032 100 µg

Human WARS1 Recombinant Protein

Ask

View Details